Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

This study is currently recruiting participants.

Verified May 2012 by Merrimack Pharmaceuticals

Sponsor:

Information provided by (Responsible Party):

Merrimack Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT01520389

First received: January 13, 2012

Last updated: May 1, 2012

Last verified: May 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	February 2014
Estimated Primary Completion Date:	October 2013 (Final data collection date for primary outcome measure)